Education
Stanford University, Stanford, CA 94305, B.S., 1973 - 1977.
Medical College of Virginia, Richmond, VA. 23298, M.D., 1977 - 1981.
St. Mary's Hospital, Waterbury, CT 06702, Internal Medicine, Intern 1981 - 1982, Resident 1982 - 1984.
Duke University Medical Center, Durham, NC 27710, Radiation Oncology, Resident 1984 - 1986, Chief Resident, 1986 - 1987.
Honors/Awards
Am Cancer Soc Clin Fellowship, 1986 - 1987.
Am Soc Ther Radiol and Oncol Travel Award, Malmo, Sweden, 1992.
Alter Del to NC Med Soc, 1992 - 1993; Del to NC Med Soc 1993 - 1995.
Duke Cancer Ctr Patient Support Prog Advisory Bd, 1988 - present.
Alter Member, Cancer Comm, Moore Reg Hosp, 1990 - present.
Alternate, Cancer Ctr Protocol Rev Comm, 1991 - 1992.
Co-Vice Chair, Cancer Ctr Protocol Rev Comm, 1992 - present.
Am Soc Ther Radiol and Oncol.
Am Coll Radiol, Am Coll Phys, Am Radium Soc, Am Soc Clin Oncol.
NC Med Soc.
Radiat Res Soc.
Employment
Assist Prof, Radiat Oncol, Duke Univ Med Ctr, Durham NC, 1987 - present.
Attend Radiat Oncologist, Moore Regional Hospital, Pinehurst NC, 1987 - present.
Consultant, Eastern Cooperative Oncol Group Genitourinary Committee, 1989 - present.
Principal Invest, Radiat Ther Oncol Grp, Duke Univ Med Ctr, Durham NC, 1991 - present.
Consult Radiat Oncol, Mem Hosp Martinsville and Henry County, Martinsville VA, 1991 - present.
Consult Radiat Oncol, Durham Reg Hosp, Durham NC, 1992 - present.
Publications
1. Anscher MS, Prosnitz LR: RE: Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 143:1238-1239, 1990.
2. Rossitch EJ, Zeidman SM, Burger PC, Curnes JT, Harsh C, Anscher MS, Oakes WJ: Clinical and pathological analysis of spinal cord astrocytomas in children. Neurosurgery 27:193-196, 1990.
3. Anscher MS, Crocker IR, Jirtle RL: Transforming growth factor-beta 1 eXpression in irradiated liver. Radiat Res 122:77-85, 1990.
4. Marks LB, Anscher MS, Shipley WU: The role of radiation therapy in the treatment of testicular germ cell tumors. Hematol Oncol Clin North Am 5:1143-1172, 1991.
5. Anscher MS, Prosnitz LR: Multivariate analysis of factors predicting local relapse after radical prostatectomy--possible indications for postoperative radiotherapy [see comments]. Int J Radiat Oncol Biol Phys 21:941-947, 1991.
6. Anscher MS, Clark RE: Radiotherapy for non-melanoma skin cancer. Dispelling the myths. NC Med. 52:122-124, 1991.
7. Anscher MS, Gold DT: Literacy and laryngectomy: how should one treat head and neck cancer in patients who cannot read or write? South Med J 84:209-213, 1991.
8. Anscher MS, Prosnitz LR: Transurethral resection of prostate prior to definitive irradiation for prostate cancer. Lack of correlation with treatment outcome. Urology 38:206-211, 1991.
9. Montana GS, Anscher MS, Mansbach CMd, Daly N, Delannes M, Carke-Pearson D, Gaydica EF: Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A phase I/II trial. Cancer 69:2826-2830, 1992.
10. Marks LB, Anscher MS : Radiotherapy for prostate cancer: should the seminal vesicles be considered target? Int J Radiat Oncol Biol Phys 24:435-440, 1992.
11. Anscher MS, Samulski TV, Leopold KA, Oleson JR: Phase I/II study of eXternal radio frequency phased array hyperthermia and eXternal beam radiotherapy in the treatment of prostate cancer: technique and results of intraprostatic temperature measurements. Int J Radiat Oncol Biol Phys 24:489-495, 1992.
12. Kavanagh B, Anscher M, Leopold K, Deutsch M, Gaydica E, Dodge R, Allen K, Allen D, Staub W, Montana G: Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys 24:633-642, 1992.
13. Marks LB, Anscher MS, Shipley WU: Radiation therapy for testicular seminoma: controversies in the management of early-stage disease. Oncology 6:43-48; discussion 51-52, 1992.
14. Anscher MS, Marks LB, Shipley WU: The role of radiotherapy in patients with advanced seminomatous germ cell tumors. Controversies in management. Part 2. Oncology 6:97-104; discussion 107-108, 110, 1992.
15. Anscher MS, Prosnitz LR: Prognostic significance of eXtent of nodal involvement in stage D1 prostate cancer treated with radiotherapy. Urology 39:39-43, 1992.
16. Anscher MS, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, Tucker A, Dodge R, Leight GJ, Iglehart JD: Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218:22-28, 1993.
17. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL: Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328:1592-1598, 1993.
18. Halperin EC, Anscher MS, Fraser RW, Thomas CC, Walther PH. Screening for prostate cancer utilizing the prostate-specific antigen (PSA). North Carolina Medical Journal 54:443-446, 1993.
19. Anscher MS, Montana GS, Dodge R, Gaydica EF, Dewhirst MW, Prosnitz LR. The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate. Int J Radiat Oncol 3:707-711, 1993.
20. Anscher MS, Montana G. Radiotherapy for the management of periocular basal call carcinoma. Survey of Ophthalmology, in press, 1993.
21. Kavanagh BD, Montana GS, Crawford J, Wolfe WG, Anscher MS. Long-term results of combined modality therapy for esophageal cancer. Radiation Oncology Investigations, in press, 1993.